224 completed, 17 unknown, 9 recruiting, 7 not yet recruiting. 273 Phase 1, 29 Phase 2.
Follow Tablets: new trials by email Literature Review of Tablets trials Research Report on Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN Tetramethylpyrazine nitrone (TBN) tablet / Placebo - Healthy | Phase 1 | Not yet recruiting | Guangzhou Magpie Pharmaceuticals Co., Ltd. | 16 | 2028-09-01 | 2026-09-11 |
| A Multicenter Safety and Immunogenicity Window-of-opportunity Phase 1 Interventional Trial Assessing the Combination of IDH1 Vaccine (IDH1-vac) and Vorasidenib in Adult Patients With Recurrent IDH1R132H-mutant Astrocytoma, Grade 2 - 4 (iVOCAL) IDH1R132H-vac, Vorasidenib 40 mg Oral Tablet, Aldara - Imiquimod 5% - Recurrent IDH1R132H-mutant Astrocytoma, Grade 2 - 4 | Phase 1 | Not yet recruiting | Heidelberg University | 45 | 2027-01-01 | 2026-10-16 |
| HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation ivermectin infant formula preparation, Standard ivermectin 3mg tablet - Scabies | Phase 1 | Suspended | Murdoch Childrens Research Institute | 52 | 2027-01-01 | 2026-10-09 |
| Study of CDK8 Inhibitor RVU120 in Combination With Everolimus in Children With Recurrent or Progressive Group 3 or 4 Medulloblastoma RVU120, Everolimus (Afinitor) tablets - Medulloblastoma Recurrent, Medulloblastoma | Phase 1 | Not yet recruiting | Bożenna Dembowska Bagińska | 48 | 2026-09-01 | 2026-10-08 |
| Role of Medication in Making Urine Less Acidic as Part of Kidney Stone Prevention Potassium Citrate Extended Release Oral Tablet - Kidney Calculi | Phase 1 | Not yet recruiting | University of Texas Southwestern Medical Center | 20 | 2026-07-01 | 2026-02-05 |
| Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis Dapagliflozin (10Mg Tab) along with standard medical therapy, Proteinuria Quantification - Lupus Nephritis (LN), Chronic Kidney Disease | Phase 1 / Phase 2 | Active not recruiting | Hospital Civil Juan I. Menchaca | 30 | 2026-05-28 | 2026-07-01 |
| MTOR Inhibitors in Older Adults Sirolimus 0.5 Mg Oral Tablet, Sirolimus 1Mg Oral Tablet, Sirolimus 2 MG Oral Tablet - Aging | Phase 1 / Phase 2 | Recruiting | University of Texas Southwestern Medical Center | 60 | 2026-05-11 | 2026-06-25 |
| Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE) Everolimus (Afinitor) tablets - Colorectal Cancer | Phase 1 / Phase 2 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 38 | 2026-03-01 | 2026-02-27 |
| A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. metformin hydrochloride 500 mg tablet, rosuvastatin 10 mg tablet, repaglinide 0.5 mg tablet - TP53 Y220C Mutation, Advanced Solid Tumors | Phase 1 | Recruiting | PMV Pharmaceuticals, Inc | 14 | 2026-02-04 | 2026-08-12 |
| Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG) Brenzavvy (bexagliflozin), 20 mg Oral Tablet, Placebo - Angina Patients With Non-obstructive Coronary Artery Disease, Coronary Microvascular Disease | Phase 1 | Recruiting | University of Virginia | 150 | 2025-07-15 | 2026-09-09 |
| Excretion of Rivaroxaban in Human Breast Milk Rivaroxaban 10 MG Oral Tablet, Rivaroxaban 20 MG Oral Tablet - Postpartum, VTE Prophylaxis | Phase 1 | Recruiting | Thomas Jefferson University | 10 | 2025-07-01 | 2025-07-17 |
| Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia) Azilsartan medoxomil 80 mg tablet, Edarbi® 80 mg tablets - Hypertension | Phase 1 | Not yet recruiting | Gedeon Richter Plc. | 56 | 2025-06-06 | 2025-05-25 |
| A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects LUCEMYRA (lofexidine) tablets - Opioid Withdrawal (Disorder), Opioid Use Disorder | Phase 1 | Withdrawn | USWM, LLC (dba US WorldMeds) | 2025-06-01 | 2025-08-01 | |
| A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC FWD1802, Palbociclib 125mg, Ribociclib 200Mg Oral Tablet - Metastatic Breast Cancer, Breast Cancer Stage I | Phase 1 / Phase 2 | Recruiting | Forward Pharmaceuticals Co., Ltd. | 196 | 2025-06-01 | 2026-01-07 |
| Pentoxifylline for Vascular Calcification in Kidney Disease Pentoxifylline 400 MG Oral Tablet, Conventional Medications for Chronic Kidney Disease - Chronic Kidney Disease, Vascular Calcification | Phase 1 / Phase 2 | Not yet recruiting | Mansoura University | 80 | 2025-04-15 | 2025-04-01 |
| Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis Metformin Hydrochloride 500Mg Tablet, Pirfenidone (PFD), Beclomaethasone and Vitamin E - Oral Submucous Fibrosis | Phase 1 / Phase 2 | Completed | Ziauddin University | 45 | 2025-04-07 | 2026-02-03 |
| EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL Colchicine 0.5 MG Oral Tablet - COVID - 19 | Phase 1 / Phase 2 | Completed | Zaeema Kanwal | 66 | 2025-02-24 | 2025-09-04 |
| KF2024#1-trial: Esketamine Interaction Study Esketamine Nasal Spray, Esketamine 28 mg, Cobicistat 150 MG - Drug Interactions, Food-drug Interaction | Phase 1 | Completed | Helsinki University Central Hospital | 12 | 2024-12-09 | 2026-03-05 |
| Patient Controlled Administration of Liquid Acetaminophen Acetaminophen 650 mg Oral Tablet, Acetaminophen 650mg Liquid, CADD pump - Pain, Pain, Postoperative | Phase 1 | Completed | Yale University | 24 | 2024-11-19 | 2026-08-06 |
| Prevention of Progression of Prediabetes, Obesity and CV Risk Placebo, Rybelsus Tablet, Jardiance 25Mg Tablet - Pre-Diabetes, Weight, Body | Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 64 | 2024-09-11 | 2025-11-12 |
Showing 20 of 273. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (9) · HIV Infections (7) · Hypertension (5) · Neoplasms (5) · Pain (5) · Diabetes Mellitus, Type 2 (4) · Infections (4) · Renal Insufficiency, Chronic (4) · Anemia (3) · Chronic Pain (3) · Neoplasm Metastasis (3) · Schizophrenia (3) · Venous Thromboembolism (3) · Vomiting (3) · Alopecia (2)
GlaxoSmithKline (11) · Boehringer Ingelheim (9) · Mutual Pharmaceutical Company, Inc. (9) · Actavis Inc. (8) · AstraZeneca (8) · Teva Pharmaceuticals USA (7) · Bayer (5) · Chong Kun Dang Pharmaceutical (5) · NewAmsterdam Pharma (5) · ViiV Healthcare (5) · Pfizer (4) · Sandoz (4) · Daewoong Pharmaceutical Co. LTD. (3) · Lakefront Biotherapeutics NV (3) · Merck Sharp & Dohme LLC (3)
United States (99) · South Korea (17) · United Kingdom (17) · Canada (13) · China (12) · Germany (9) · Egypt (8) · India (7) · Belgium (6) · Netherlands (6) · Australia (5) · Pakistan (5) · Russia (4) · Switzerland (4) · Japan (3)
Benoit Girard, M.D. (4) · Anthony R Godfrey, Pharm.D. (2) · Antonio R. Pizarro,, M.D. (2) · Daniela Baldoni, PharmD, PhD (2) · Eric Masson, Pharm.D. (2) · Gaetano Morelli,, MD (2) · Irina Rodyukova (2) · James D. Carlson, Pharm. D. (2) · James D. Carlson, Pharm.D. (2)
PMID 11705426, PMID 12537512, PMID 15793367, PMID 15907596, PMID 17707845, PMID 20114004, PMID 20453709, PMID 20455886, PMID 21723605, PMID 24095247, PMID 24610312, PMID 25880846, PMID 29803534, PMID 30649458, PMID 30807645, PMID 31140114, PMID 31405822, PMID 33113596, PMID 33188747, PMID 33744986, PMID 33813736, PMID 33825964, PMID 34123370, PMID 34384282, PMID 34471960, PMID 34817414, PMID 34866168, PMID 35001638, PMID 35470225, PMID 35583344, PMID 38833144, PMID 39194204, PMID 40170587, PMID 40569335, PMID 41332264, PMID 42518155, PMID 42678337, PMID 7227774, PMID 7452494, PMID 7751691, PMID 7769277, PMID 9098665, PMID 9989342
2015 (3), 2014 (2), 2018 (2), 2023 (2), 1UG3DA061620 (1), 2016 (1), 2017 (1), 2019 (1), P20DA024157 (1), R01DA047690 (1), R21AI145646 (1), T32HD069038 (1), U01AG081450 (1)